celltrion

Investment

top

Financial information

  • 바이오시밀러
  • 투자정보
  • 오시는 길
  • Ochang new construction plant
  • Biosimilar
Home  |  Investment  |  Financial information
Consolidated Statement of Financial Position
Unit : Million Won
2017 ~ 2019 연결 재무상태표
Classification 2019 2018 2017
Current assets 188,855 199,961 211,107
Non - Current assets 282,125 252,483 259,162
Total assets 470,980 452,444 470,269
Current liabilities 149,138 145,034 124,290
Non - Current liabilities 41,811 37,375 52,355
Total liabilities 190,949 182,409 176,645
Issued capital 263,549 310,878 309,705
Retained earnings 11,168 (45,123) (20,909)
Elements of other stockholder's equity 5,314 4,280 4,828
Total equity 280,031 270,035 293,624
Total equity and liabilities 470,980 452,444 470,269
Consolidated Statement of Comprehensive Income
Unit : Million Won
2017 ~ 2019 연결 재무상태표
Classification 2019 2018 2017
Revenue(Sales) 173,513 146,880 135,860
Operating income(loss) 14,735 3,569 8,671
Profit (loss) before tax 8,845 (6,260) 2,464
Profit (loss) 8,602 (9,389) 2,715